Kidney Cancer Journal

Nivolumab: 5 Years Since FDA Approval of the First Checkpoint Inhibitor for Renal Cell Carcinoma...

Renal Function: Implications on the Surgical Treatment of RCC Abstract The good oncologic results...

The Trouble with Doublets: Making Sense of Combination Strategies in Advanced Kidney Cancer...

Eighteenth International Kidney Cancer Symposium, November 15-16, 2019, Trump National Doral Miami...

The Pan-Omics Landscape of Renal Cell Carcinoma and Its Implication on Future Clinical Practice...